Právní předpis byl sestaven k datu 17.02.2025.
Zobrazené znění právního předpisu je účinné od 17.12.2016.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2017
390/2016 Sb.
390
XXXXXXX
Xxxxxxxxxxxx zdravotnictví
ze xxx 28. listopadu 2016
x xxxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx rok 2017
Xxxxxxxxxxxx xxxxxxxxxxxxx podle §80 xxxx. 1 xxxx. x) xxxxxx x. 258/2000 Xx., x ochraně xxxxxxxxx xxxxxx x o xxxxx některých xxxxxxxxxxxxx xxxxxx, xx znění xxxxxxxxxx xxxxxxxx, stanoví xx xxxxxxx doporučení Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x mimořádná xxxxxxxx xxx xxx 2017:
1. Xxxxxxxxx složení xxxxxxxxxx látek pro xxxxxxxxxx očkování
1a) xxxxxxxxxxx xxxxxxxx xxxxx proti xxxxxxx, dávivému kašli (xxxxxxxxxx xxxxx), tetanu, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx), virové xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (DTaPHibVHBIPV):
Diphtheriae xxxxxxxxxx1 xx xxxx xxx 30 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxx xxxxxxxxxx1 xx xxxx xxx 40 xxxxxxxxxxxxx jednotek (XX)
Xxxxxxxx Bordetelly pertussis:
Pertussis xxxxxxxxxx1 25 xxxxxxxxxx
Xxxxxxxxxxxxxxxx xxxxxxxxxxxx1 25 xxxxxxxxxx
Xxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx tegiminis xxxxxxxxxxx X2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxx (xxxxxxxxxxxx)
xxxxx 1 (xxxx Xxxxxxx)4 40 X jednotek xxxxxxxx
xxxxx 2 (xxxx XXX-1)4 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Xxxxxxx)4 32 X jednotek antigenu
Haemophilus xxxxxxxxxx xxxxx b xxxxxxxxxxxxxxx 10 xxxxxxxxxx
(xxxxxxxxxxxxxxxxxxx xxxxxxxx)3
xxxxxxxxx xxx xxxxxx xxxxxxxxxx xxxx xxxxxx xxxxxxxxx xxxxxxxxx 25 xxxxxxxxxx
XXXX
1xx) xxxxxxxxxxx xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), xxxxxx, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx hepatitidě X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xxxxxxxxxxx xxxxxxxxxx xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX)2
Xxxxxx xxxxxxxxxx xx xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)2
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx xxxxxxxxxx 25 xxxxxxxxxx
Xxxxxxxxxxxxxx filamentosum 25 xxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3
xxxxx 1 (Xxxxxxx) 40 X xxxxxxxx xxxxxxxx4
xxxxx 2 (MEF-1) 8 X xxxxxxxx xxxxxxxx4
xxxxx 3 (Xxxxxxx) 32 X jednotek xxxxxxxx4
Xxxxxxxxx xxxxxxxxx xxxxxxxxxx X5 10 mikrogramů
Haemophilus xxxxxxxxxx xxxx x xxxxxxxxxxxxxxx 12 xxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)
xxxxxxxxx cum tetani xxxxxxxxxx 22-36 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), tetanu (XXxX):
Xxxxxxxxxxx xxxxxxxxxx ³ 30 mezinárodních xxxxxxxx
Xxxxxx xxxxxxxxxx ³ 40 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx (69kD) 8 xxxxxxxxxx
XXXX
1xx) Očkovací xxxxx xxxxx záškrtu, xxxxxx a xxxxxxxx xxxxx (xxxxxxxxxx)
1 xxxxx (0,5 xx) xxxxxxxx: Xxxxxxxxxxx xxxxxxxxxx |
Xxxxxxxxx 2 XX* (2 Xx) |
Xxxxxx xxxxxxxxxx |
Xxxxxxxxx 20 IU* (5 Xx) |
Xxxxxxxxx antigeny |
|
Pertussis xxxxxxxxxx |
2,5 xxxxxxxxxx |
Xxxxxxxxxxxxxx filamentosum |
5 xxxxxxxxxx |
Xxxxxxxxxxx |
3 xxxxxxxxxx |
Xxxxxxxx, xxxx 2 xx 3 |
5 xxxxxxxxxx |
Xxxxxxxxxxx xx fosforečnan xxxxxxx |
1,5 xx (0,33 xx xxxxxxx) |
XXXX
1xx) Očkovací xxxxx proti xxxxxxx, xxxxxx x xxxxxxxx xxxxx (acelulární xxxxxxxxxx) xx xxxxxxxx obsahem xxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx než 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Lf)
Tetani xxxxxxxxxx1 xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Lf)
Bordetellae xxxxxxxxx antigena:
Pertussis xxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx externae proteinum1 2,5 xxxxxxxxxx
1 adsorbováno xx hydratovaný xxxxxxxx xxxxxxx (XX(XX)3) 0,3 xxxxxxxxx AI3+
a xxxxxxxxxxx xxxxxxx (AIP04) 0,2 xxxxxxxxx AI3+
1c) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), tetanu, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx x (XXxXXxx):
Xxxxxxxxxxx xxxxxxxxxx |
xxx. 30 xxxxxxxxxxxxx xxxxxxxx |
Xxxxxx xxxxxxxxxx |
xxx. 40 mezinárodních xxxxxxxx |
Xxxxxxxxx xxxxxxxxxx (PT) |
25 xxxxxxxxxx |
Xxxxxxxxx haemaglutininum xxxxxxxxxxxx |
(XXX) 25 xxxxxxxxxx |
Xxxxxxxxxxx (69xX) |
8 xxxxxxxxxx |
Xxxxxxxxxxx xxxxxxxxxx X |
10 xxxxxxxxxx |
xxx anatoxino xxxxxxxx |
20-40 xxxxxxxxxx |
1x) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx typ x:
1 dávka lyofilizované xxxxxxx xxxxxxxx: Polysaccharidum Xxx purificatum (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).
1x) očkovací látka xxxxx xxxxxx:
Xxxxxx anatoxinum … min. 40 xxxxxxxxxxxxx jednotek
1f) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B od 16 xxx x xxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X |
20 mikrogramů |
1g) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X x xxxxxx formuli:
Antigenum xxxxxxxxx xxxxxxxxxxx X |
10 xxxxxxxxxx |
1x) xxxxxxxx látka xxxxx xxxxxxxxxx, příušnicím x xxxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx (Xxxxxxx) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx kulturu50 Xxxxxxxxxxx xxxxx xxxxxxxxxx (XXX 4385) min. 103,7 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx50 Xxxxxxxx xxxxx attenuatum (Xxxxxx XX 27/3) min. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx50
1xx) xxxxxxxx látka xxxxx xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx xxxxx:
Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 1 (Mahoney) … 40 antigenních D xxxxxxxx*
Xxxxx poliomyelitis inactivatum xxxxx 2 (MEF-1) … 8 antigenních X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 3 (Xxxxxxx) … 32 xxxxxxxxxxx D xxxxxxxx*
* xxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx stanovené xxxxxx xxxxxx xxxxxxxxxxxxx xxxxxx.
1x) xxxxxxxx xxxxx xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx v xxxxxxxxxxxxxxx xxxxxxx:
Xxxxxxxxxxxxxxx Xxxxxxxxxxxx pneumoniae xxxxx:
1, 2, 3, 4, 5, 6X, 7X, 8, 9N, 9X, 10X, 11X, 12X, 14, 15X, 17X,
18X, 19X, 19X, 20, 22X, 23F, 33X … 25 xxxxxxxxxx x každého xxxxxxxx
1x) očkovací xxxxx xxxxxxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 3
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 4
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 5
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X
Xxxxxxxxxxxxx polysaccharidum sérotypus 9X
Xxxxxxxxxxxxx polysaccharidum sérotypus 14
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19X
Xxxxxxxxxxxxx polysaccharidum sérotypus 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 23X
1x) xxxxxxxx látka xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx forma):
Xxxxxxxxxxx xxxxxxxxxx |
xx méně xxx 2 xxxxxxxxxxx xxxxxxxx |
Xxxxxx anatoxinum |
ne méně xxx 20 mezinárodních xxxxxxxx |
Xxxxxxxxx xxxxxxxx: |
|
Xxxxxxxxx anatoxinum |
8 xxxxxxxxxx |
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx |
8 xxxxxxxxxx |
Xxxxxxxxx |
2,5 xxxxxxxxxx |
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx: |
|
xxxxx 1 (xxxx Xxxxxxx) |
40 X xxxxxxxx xxxxxxxx |
xxxxx 2 (xxxx XXX-1) |
8 X jednotek xxxxxxxx |
xxxxx 3 (xxxx Xxxxxxx) |
2 X xxxxxxxx xxxxxxxx |
XXXX
1x) xxxxxxxx látka xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx forma), xxxxxx, dětské přenosné xxxxx (inaktivovaná xxxxx):
Xxxxxxxxxx xxxxxx |
xxxx xxxx xxxxx 2 xxxxxxxxxxx xxxxxxxx (2 Lf) |
Tetanický toxoid |
více xxxx xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Xx) |
Xxxxxxxxx antigeny: |
|
Xxxxxxxxx xxxxxx |
2,5 xxxxxxxxxx |
&xxxx;&xxxx; Filamentózní xxxxxxxxxxxx |
5 xxxxxxxxxx |
&xxxx;&xxxx; Xxxxxxx xxxx 2+3 |
5 xxxxxxxxxx |
&xxxx;&xxxx; Xxxxxxxxx |
3 mikrogramy |
Virus poliomyelitis xxxx 1 (xxxxxxxxxxxx) |
40 xxxxxxxxxxx X xxxxxxxx |
Xxxxx xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx) |
8 xxxxxxxxxxx X xxxxxxxx |
Xxxxx xxxxxxxxxxxxx xxxx 3 (xxxxxxxxxxxx) |
32 xxxxxxxxxxx X jednotek |
1m) xxxxxxxx xxxxx xxxxx xxxxxxxxxxx (XXX vakcína)
1n) očkovací xxxxx proti virové xxxxxxxxxx B pro xxxxx zařazené xx xxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxx tegiminis xxxxxxxxxxx X biosyntheticum 20 xxxxxxxxxx; xxxxxxxx XX04X obsahující 3-O-deacyl-4-monofosforyl-lipid X (XXX) 50 xxxxxxxxxx x 1 xxxxx
2. Xxxxxxxxx složení xxxxxxxxxx xxxxx pro xxxxxxxx xxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx pro dospělé:
Antigenum xxxxxxxxx hepatitidis X |
20 xxxxxxxxxx |
2x) xxxxxxxx látka xxxxx vzteklině
2c) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx xxx dospělé:
Hepatitis X virus xxxxxxxxxxx
3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxx
3x) xxxxxxxx látka xxxxx virové xxxxxxxxxx X xx formuli xxx xxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
3x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X xx xxxxxxx pro xxxx:
Xxxxx xxxxxxxxx X xxxxxxxxxxx
X xxxx 2017 x xxxxxxx xx xxxxxxxxxx xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x xxxxxxxx xxxxx xxxxxxxxx xxxxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx, xxxxx xxxxxxxx xxxxxxxxx xxxxxx antigenního xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx očkování xxxxxxxxxxxx xxxxxx xxxxxxxxxxx složení xxxxxx xxxxxxxxxx látek xx Xxxxxx zákonů.
Ministr:
MUDr. Xxxxxxx, XXX, x. x.
Xxxxxxxxx
Xxxxxx xxxxxxx x. 390/2016 Sb. xxxxx xxxxxxxxx xxxx 17.12.2016.
Ke xxx uzávěrky právní xxxxxxx xxxxx xxxxx xx xxxxxxxxx.
Xxxxx jednotlivých xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx uvedeného xxxxxxxx xxxxxxxx.